|
UBAP2L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.120600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.929600E-01 |
| Normal-vs-Stage2 |
5.038200E-01 |
| Normal-vs-Stage3 |
4.548400E-01 |
| Normal-vs-Stage4 |
8.156600E-03 |
| Stage1-vs-Stage2 |
2.120000E-01 |
| Stage1-vs-Stage3 |
8.198800E-01 |
| Stage1-vs-Stage4 |
1.857810E-02 |
| Stage2-vs-Stage3 |
2.181000E-01 |
| Stage2-vs-Stage4 |
5.303100E-03 |
| Stage3-vs-Stage4 |
5.650400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.310600E-01 |
| Normal-vs-AfricanAmerican |
4.200600E-03 |
| Normal-vs-Asian |
4.076200E-01 |
| Caucasian-vs-AfricanAmerican |
1.975010E-03 |
| Caucasian-vs-Asian |
9.556600E-01 |
| AfricanAmerican-vs-Asian |
1.717830E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.534400E-01 |
| Normal-vs-Female |
4.011800E-01 |
| Male-vs-Female |
5.850400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.404200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.433000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.377200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.994800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.015800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.802800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.123200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.070400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.231800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.529800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.038600E-01 |
| Classical-VS-Follicular |
3.72220032573978E-10 |
| Classical-VS-Other |
1.728810E-01 |
| Classical-VS-Normal |
7.898500E-03 |
| Tall-VS-Follicular |
5.183100E-03 |
| Tall-VS-Other |
3.757400E-01 |
| Tall-VS-Normal |
4.534800E-01 |
| Follicular-VS-Other |
4.701600E-01 |
| Follicular-VS-Normal |
4.816600E-03 |
| Other-VS-Normal |
5.755600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.277000E-01 |
| Normal-vs-N1 |
4.223600E-02 |
| N0-vs-N1 |
4.296600E-03 |
|
|
